Evidence map›Paper›PMID 35600708›Full record

ArticleSAGE open medicine2022

Spectrum of thyroid function test among type 2 diabetic patients attending a rural health facility, southwest Nigeria: A hospital-based study.

Ahmed Kayode Jimoh, Muritala Segun Ghazali, Olajumoke Ajele Ogundeji, Babajide Adewoyin Adeleke, Oladimeji Gbadebo Ajani, Emmanuel Olusegun Gabriel-Alayode, Gbenga Omotade Popoola, Olufemi Sola Adediran

Open access · goldAbstract read
In one paragraph

Article in SAGE open medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ahmed Kayode JimohDepartment of Chemical Pathology, Afe Babalola University, Ado-Ekiti, Nigeria.ORCID https://orcid.org/0000-0001-8414-202X
Muritala Segun GhazaliDepartment of Chemical Pathology, Afe Babalola University, Ado-Ekiti, Nigeria.
Olajumoke Ajele OgundejiDepartment of Chemical Pathology, Afe Babalola University, Ado-Ekiti, Nigeria.
Babajide Adewoyin AdelekeDepartment of Chemical Pathology, Federal Teaching Hospital, Ido-Ekiti, Nigeria.
Oladimeji Gbadebo AjaniDepartment of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.ORCID https://orcid.org/0000-0002-7551-7835
Emmanuel Olusegun Gabriel-AlayodeDepartment of Family Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.
Gbenga Omotade PopoolaDepartment of Epidemiology and Community Health, University of Ilorin, Ilorin, Nigeria.
Olufemi Sola AdediranDepartment of Medicine, Afe Babalola University, Ado-Ekiti, Nigeria.
Afe Babalola University · NGEkiti State University · NGUniversity of Ilorin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The thyroid gland produces hormones that have significant influence on carbohydrate metabolism; its disorders may affect carbohydrate metabolism in type 2 diabetic patients (T2DM) more than the non-diabetic (NDM) patients as reported in various studies. We determined the spectrum of thyroid function tests (TFTs) profile among T2DM in our rural health facility. Methods: T2DM patients and NDM patients were recruited for the study. The age, educational level, occupation, marital status, and duration of diabetes were extracted from interviewer's administered questionnaire. The weight, height, body mass indices (BMIs), and the waist and hip circumferences were measured. Waist-hip ratios (WHR) were calculated for all participants. Venous blood was collected and assayed for free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone (TSH) using a Chemiluminescence Immunoassay (CLIA) 2nd Generation Autoanalyzer. The mean, standard deviation, frequencies, and percentages were calculated for the variables. The student's t-test and chi-square test were also determined as appropriate. Results: Seventy-eight patients made up of 56 T2DM and 22 NDM were evaluated in this study. Fifty-one were males while 27 were females; 67.9% and 59.1% of the female participants were T2DM and NDM, respectively. The WHR was significantly higher in T2DM than NDM (0.92 ± 0.05 versus 0.88 ± 0.06). The TSH was higher in T2DM than the NDM. Forty-four (78.6%) of the T2DM had euthyroid (normal) biochemical pattern; 12 (21.4%) showed abnormal biochemical pattern of euthyroid sick syndrome, subclinical hyperthyroid, and subclinical hypothyroid. Thirty (53.6%) of the T2DM were diagnosed less than five years ago. The value of TSH was increasing with the duration of diabetes but not in a statistically significant way. None of the T2DM showed overt hypothyroid or hyperthyroid test result. Conclusion: Thyroid function test may identify diabetics with altered thyroid hormone status that may impact on their metabolic control. Knowledge of the functional state of the thyroid gland can help in achieving a better metabolic control and attenuate the development of complications in T2DM.

Indexed as

diabetes managementrural NigeriaThyroid function teststype 2 diabetes mellitus

Identifiers

PMID35600708
PMCPMC9118895
OpenAlexW4285111847

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.